Published in J Immunol on October 01, 2001
Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol (2012) 3.81
Identification and characterization of circulating human transitional B cells. Blood (2005) 3.62
Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol (2008) 2.85
Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A (2006) 2.54
Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med (2005) 2.53
B-cell responses to vaccination at the extremes of age. Nat Rev Immunol (2009) 2.50
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood (2009) 2.50
Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin Cytom (2010) 2.38
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med (2009) 2.11
Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol (2009) 2.05
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A (2004) 1.91
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood (2006) 1.73
Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood (2012) 1.70
The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci U S A (2003) 1.53
ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity (2008) 1.43
Advances in human B cell phenotypic profiling. Front Immunol (2012) 1.41
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome. Ann Rheum Dis (2006) 1.38
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study. Arthritis Res Ther (2006) 1.30
A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology (2006) 1.27
Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J (2008) 1.27
Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.26
Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res (2009) 1.24
B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther (2007) 1.16
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis (2006) 1.12
Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc Natl Acad Sci U S A (2007) 1.09
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies. Arthritis Res Ther (2013) 1.07
Aberrant B-cell homeostasis in chronic GVHD. Blood (2015) 1.06
Hyperactivated B cells in human inflammatory bowel disease. J Leukoc Biol (2009) 1.03
Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol (2005) 1.03
B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells. Am J Transplant (2012) 1.03
Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis. Clin Vaccine Immunol (2011) 1.03
Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol (2013) 1.01
Human innate B cells: a link between host defense and autoimmunity? Springer Semin Immunopathol (2005) 0.98
The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development. Hum Mol Genet (2012) 0.97
Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor. Eur J Immunol (2007) 0.97
Clinical applications for biomarkers of acute and chronic graft-versus-host disease. Biol Blood Marrow Transplant (2012) 0.95
Is the blood B-cell subset profile diagnostic for Sjogren syndrome? Ann Rheum Dis (2008) 0.95
Sjögren's syndrome: still not fully understood disease. Rheumatol Int (2014) 0.93
Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol (2006) 0.92
CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis. J Leukoc Biol (2013) 0.91
B lymphocytes: development, tolerance, and their role in autoimmunity-focus on systemic lupus erythematosus. Autoimmune Dis (2013) 0.90
Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol (2012) 0.89
Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response. PLoS One (2015) 0.89
Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF. J Clin Immunol (2004) 0.88
Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies. J Clin Immunol (2007) 0.87
Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome. Arthritis Res (2002) 0.87
Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS One (2014) 0.87
Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus. J Virol (2013) 0.84
Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren's syndrome. Arthritis Res Ther (2014) 0.82
Alterations in the peripheral blood B cell subpopulations of multidrug-resistant tuberculosis patients. Clin Exp Med (2013) 0.81
Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome. J Leukoc Biol (2015) 0.81
Translating transitions - how to decipher peripheral human B cell development. J Biomed Res (2015) 0.81
Low-dose IL-2 selectively activates subsets of CD4(+) Tregs and NK cells. JCI Insight (2016) 0.80
B-cell responses to HIV infection. Immunol Rev (2017) 0.80
Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome. Clin Exp Immunol (2013) 0.80
B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome. J Clin Immunol (2012) 0.79
Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study. Arthritis Res Ther (2013) 0.79
A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus. Clin Exp Immunol (2015) 0.79
Possible Mechanisms of Lymphoma Development in Sjögren's Syndrome. Curr Immunol Rev (2013) 0.78
Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. Clin Exp Immunol (2016) 0.78
Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells. Immunol Cell Biol (2014) 0.78
Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study. BMC Pregnancy Childbirth (2016) 0.78
Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients. Am J Transplant (2015) 0.77
Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells. Arthritis Rheumatol (2014) 0.77
Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients. Retrovirology (2016) 0.77
CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells. Infect Immun (2011) 0.77
A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)). Immunogenetics (2015) 0.76
Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura. Clin Exp Immunol (2015) 0.76
Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS One (2016) 0.75
Expression of the inherently autoreactive idiotope 9G4 on autoantibodies to citrullinated peptides and on rheumatoid factors in patients with early and established rheumatoid arthritis. PLoS One (2014) 0.75
Multiple Roles for B-Lymphocytes in Sjogren's Syndrome. J Clin Med (2016) 0.75
Long-term immunologically competent human peripheral lymphoid tissue cultures in a 3D bioreactor. Biotechnol Bioeng (2011) 0.75
High-dose methylprednisolone pulse therapy upregulated FcγRIIb expression on B cells in primary Sjögren's syndrome patients with thrombocytopenia. Clin Rheumatol (2013) 0.75
B cell phenotypes in patients with rheumatoid arthritis relapsing after Rituximab: Expression of B cell activating factor-binding receptors on B cell subsets. Clin Exp Immunol (2017) 0.75
IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol (1999) 3.52
Identification of three different human lymphocyte populations by surface markers. Transplant Rev (1973) 3.41
Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes. Adv Immunol (1973) 3.25
A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest (1974) 2.78
Immunglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells. Clin Exp Immunol (1972) 2.70
Surface-bound immunoglobulin as a marker of B lymphocytes in man. Nat New Biol (1971) 2.62
Small RNA regulators and the bacterial response to stress. Cold Spring Harb Symp Quant Biol (2006) 2.31
Surface-bound immunoglobulin on lymphocytes from normal and immunodeficient humans. Scand J Immunol (1972) 2.31
The cost-effectiveness of air bags by seating position. JAMA (1997) 2.09
Characterization of IgG complexes in eluates from rheumatoid tissue. Clin Exp Immunol (1971) 1.99
A comparison of the haemagglutination-inhibition test and the neutralisation test for the detection of rubella antibody. Lancet (1967) 1.98
Antigenic and chemical characterization of non-immunoglobulin amyloid proteins. Scand J Immunol (1972) 1.97
Glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase are differentially regulated in rats by dietary selenium. J Nutr (1995) 1.94
Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med (1976) 1.91
Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein. Scand J Immunol (1975) 1.89
Heterogeneity of anti-gamma-globulin factors detected by pepsin-digested human gamma G-globulin. Acta Pathol Microbiol Scand (1966) 1.88
Senile cardiac amyloid is related to prealbumin. Scand J Immunol (1980) 1.86
Reliability of reports of violent victimization and posttraumatic stress disorder among men and women with serious mental illness. J Trauma Stress (1999) 1.84
Genetic marker of the gamma-A2 subgroup of gamma-A immunoglobulins. Nature (1969) 1.76
Evidence of similar idiotypic determinants on different rheumatoid factor populations. Scand J Immunol (1979) 1.74
A "Lepore" type of hybrid gamma-globulin. Proc Natl Acad Sci U S A (1969) 1.66
Elution and characterization of lymphocytes from rheumatoid inflammatory tissue. Scand J Immunol (1975) 1.60
Immunological characterization of lymphocytes in synovial fluid from patients with rheumatoid arthritis. Scand J Immunol (1973) 1.59
Vaccination of women with the Cendehill strain of rubella virus. Practitioner (1971) 1.57
Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol (1991) 1.56
Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue. J Immunol (1992) 1.55
IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors. Clin Exp Immunol (1972) 1.51
Pepsin digestion of human G-myeloma proteins of different subclasses. I. The characteristic features of pepsin cleavage as a function of time. Clin Exp Immunol (1970) 1.50
Isolation of rubella virus from abortion material. Br Med J (1970) 1.48
Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart. Scand J Immunol (1979) 1.48
Complement-fixing intracellular complexes of IgG rheumatoid factor in rheumatoid plasma cells. Scand J Immunol (1972) 1.47
The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue. Scand J Immunol (1995) 1.47
Gm(g)--a "new" gamma-globulin factor. Nature (1966) 1.45
Binding of aggregated IgG BY HUMAN B lymphocytes independent of Fc receptors. Scand J Immunol (1974) 1.44
Localization of Gm markers to different molecular regions of the Fc fragment. Clin Exp Immunol (1971) 1.44
Amyloid-related serum protein SAA from three animal species: comparison with human SAA. J Immunol (1977) 1.43
Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia. Scand J Immunol (1973) 1.41
Driver distance from the steering wheel: perception and objective measurement. Am J Public Health (1999) 1.41
High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum. Scand J Immunol (1979) 1.41
Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol (1994) 1.41
A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded. Arthritis Rheum (1995) 1.40
Class, subclass, and allelic exclusion of membrane-bound Ig of human B lymphocytes. J Exp Med (1972) 1.37
Continuous rabbit kidney cell cultures in the diagnosis of rebella infections. Mon Bull Minist Health Public Health Lab Serv (1965) 1.37
Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol (1995) 1.37
Lack of suppressor cell activity in rheumatoid synovial lymphocytes. Scand J Immunol (1979) 1.36
Self-associating IgG rheumatoid factor represents a major response of plasma cells in rheumatoid inflammatory tissue. Ann N Y Acad Sci (1975) 1.34
Identification and characterization of different amyloid fibril proteins in tissue sections. Scand J Immunol (1977) 1.33
IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand J Immunol (1976) 1.33
Discovery and development of therapeutic aptamers. Annu Rev Pharmacol Toxicol (2010) 1.32
Immunological characterization of lymphocytes in lymphoproliferative diseases. Restriction of classes, subclasses, and Gm allotypes of membrane-bound Ig. Scand J Immunol (1972) 1.31
Senile cardiac amyloid: evidence that fibrils contain a protein immunologically related to prealbumin. Immunology (1981) 1.30
Violence in G-rated animated films. JAMA (2000) 1.30
Unique amyloid protein subunit common to different types of amyloid fibril. Nature (1973) 1.30
Characterization of an amyloid fibril protein from senile cardiac amyloid. J Exp Med (1977) 1.30
Same idiotype of B-lymphocyte membrane IgD and IgM. Formal evidence for monoclonality of chronic lymphocytic leukemia cells. Scand J Immunol (1974) 1.29
A HYBRID IgG4-IgG2 immunoglobulin. J Immunol (1974) 1.26
Delineation of two antigenic markers, "non a" and "non g" related to the genetic antigens of human gamma globulin. J Immunol (1969) 1.26
New, third class of amyloid fibril protein. J Exp Med (1974) 1.25
Rheumatoid synovial lymphocytes lack concanavalin-A-activated suppressor cell activity. Scand J Immunol (1979) 1.25
Widespread expression of netrin-1 by neurons and oligodendrocytes in the adult mammalian spinal cord. J Neurosci (2001) 1.24
Human anti-gamma-globulin antibodies specific for gamma G heavy chain subclasses. Immunology (1970) 1.22
The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR. Biochem J (1981) 1.22
Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. Biochem J (1989) 1.22
Detection of genetic markers of human immunoglobulins by immunofluorescence technique. Ann N Y Acad Sci (1971) 1.22
An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis. Scand J Immunol (1980) 1.21
Genetic variants of G4 globulin. A unique relationship to other classes of G globulin. J Exp Med (1970) 1.21
Complexities of measuring antagonist potency at P2X(7) receptor orthologs. J Pharmacol Exp Ther (2001) 1.20
Preformed ribozyme destroys tumour necrosis factor mRNA in human cells. J Mol Biol (1992) 1.20
Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol (1993) 1.20
In situ characterization of mononuclear cells in rheumatoid tissues, using monoclonal antibodies. No reduction of T8-positive cells or augmentation in T4-positive cells. Scand J Immunol (1982) 1.17
Effect of polyspecific rabbit anti-immunoglobulin antisera on human lymphocytes in vitro. Int Arch Allergy Appl Immunol (1970) 1.17
The Lyme vaccine: a cautionary tale. Epidemiol Infect (2006) 1.17
Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid. Eur J Immunol (1992) 1.17
Shared idiotypes of human peripheral blood B and T lymphocytes. J Immunol (1979) 1.16
The selenium requirement for glutathione peroxidase mRNA level is half of the selenium requirement for glutathione peroxidase activity in female rats. J Nutr (1996) 1.16
Connective tissue origin of the amyloid-related protein SAA. J Exp Med (1976) 1.16
Hidden rheumatoid factors reacting with "non a" and other antigens of native autologous IgG. J Immunol (1970) 1.14
Amyloid-related serum protein SAA in endotoxin-induced amyloidosis of the mink. J Exp Med (1976) 1.14
Specificity of receptors for IgG on human lymphocyte-like cells. Scand J Immunol (1974) 1.13
The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. J Immunol Methods (1986) 1.13
Rheumatoid factors isolated from patients with autoimmune disorders are derived from germline genes distinct from those encoding the Wa, Po, and Bla cross-reactive idiotypes. J Clin Invest (1991) 1.12
IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis. Scand J Immunol (1977) 1.11
Cytotoxicity of human lymphocytes induced by rabbit antibodies to chicken erythrocytes. Inhibition by normal IgG and by human myeloma proteins of different IgG subclasses. Immunology (1973) 1.11
Rheumatoid anti Gm gactors with specificity for the pFc' subfragment of human immunoglobulin G. Nature (1970) 1.11
Three new fragments, F(ab) 2 , F(c) 2 , and Fab-c, obtained by papain proteolysis of normal human IgG. Scand J Immunol (1972) 1.10
Rheumatoid synovial dendritic cells as stimulators in allogeneic and autologous mixed leukocyte reactions--comparison with autologous monocytes as stimulator cells. Scand J Immunol (1986) 1.10
N-terminal amino acid sequence of amyloid fibril protein AR, prototype of a new lambda-variable subgroup, V lambda V. Scand J Immunol (1974) 1.10
Deficient lymphoid cell-mediated, PHA-induced cytotoxicity in rheumatoid arthritis patients. Scand J Immunol (1975) 1.10
Detection of genetic antigens utilizing gamma globulins coupled to red blood cells. Nature (1967) 1.10
An observational study of object mouthing behavior by young children. Pediatrics (2001) 1.07
Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-alpha): in vitro function and precise epitope mapping by phage epitope library. Clin Exp Immunol (1994) 1.07
Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions. Proc Natl Acad Sci U S A (1994) 1.07
Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas. Immunology (1986) 1.06
Structural requirements in the Fc region of rabbit IgG antibodies necessary to induce cytotoxicity by human lymphocytes. Scand J Immunol (1975) 1.06
Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium. Scand J Immunol (1999) 1.06
Rheumatoid factor plaque-forming cells in rheumatoid synovial tissue. Clin Exp Immunol (1977) 1.05
Experimentally produced antibodies to the pepsin site of IgG due to untreated autologous IgG in immune complexes. Clin Exp Immunol (1970) 1.05